Background illustration for clinical trials search

Paid Clinical Trials Oakland

Discover 2,299 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: San Francisco CA, Palo Alto CA, Elk Grove CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase 2, Recruiting

Probiotic Administration for Adolescent Depression

for
Depression
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 15 - 24

Code: NCT06898788

Early Phase 1, Recruiting

A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects

for
Neuroblastoma, Neuroectodermal Tumors, Neoplasms
Location: San Francisco CA, Seattle WA, Aurora CO, Fort Worth TX,
Sponsor: Jubilant DraxImage Inc.

Sex: All

Age: 1+

Code: NCT03561259

Phase 2, Recruiting

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

for
Metastatic Renal Cell Carcinoma,
Location: San Francisco CA, Burlingame CA, San Mateo CA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05327686

Phase 2, Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: San Francisco CA, Redding CA, Bakersfield CA,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System

for
Ventilator Induced Diaphragm Dysfunction
Location: San Francisco CA
Sponsor: Lungpacer Medical Inc.

Sex: All

Age: 18+

Code: NCT07477054

Recruiting

Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation

for
Metastatic Melanoma
Location: San Francisco CA, Houston TX
Sponsor: California Pacific Medical Center Research Institute

Sex: All

Age: 18+

Code: NCT04633902

Phase 2, Recruiting

NEO100 and High-Grade Meningioma

for
Residual, Progressive or Recurrent Grade II or III Meningioma
Location: San Francisco CA, Santa Monica CA, Los Angeles CA,
Sponsor: Neonc Technologies, Inc.

Sex: All

Age: 12+

Code: NCT05023018

Phase 2, Recruiting

Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation

for
Metastatic Melanoma
Location: San Francisco CA
Sponsor: California Pacific Medical Center Research Institute

Sex: All

Age: 18+

Code: NCT03925350

Phase 2, Recruiting

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

for
Uveal Melanoma
Location: San Francisco CA
Sponsor: California Pacific Medical Center Research Institute

Sex: All

Age: 18+

Code: NCT05077280

Phase 2, Recruiting

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

for
Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Location: San Francisco CA, Columbus OH, Gainesville FL,
Sponsor: Duke University

Sex: All

Age: 2 - 21

Code: NCT06654882

Phase 3, Recruiting

Effect of Fetal Aortic Valvuloplasty on Outcomes

for
Congenital Heart Disease, Aortic Valve Stenosis,
Location: San Francisco CA, Columbus OH, Toronto
Sponsor: Queen Silvia Children's Hospital, Gothenburg, Sweden

Sex: All

Age: 0

Code: NCT05386173

Recruiting

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

for
Multiple Sclerosis, RRMS, Relapsing Remitting MS
Location: San Francisco CA
Sponsor: Ari Green

Sex: All

Age: 18+

Code: NCT07510607

Phase 2, Recruiting

Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss

for
Sensorineural Hearing Loss, Bilateral
Location: San Francisco CA, Iowa City IA, Nashville TN
Sponsor: Eli Lilly and Company

Sex: All

Age: 0+

Code: NCT05821959

Phase 3, Recruiting

Autologous Gene Therapy for Artemis-Deficient SCID

for
Severe Combined Immunodeficiency
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 0+

Code: NCT03538899

Phase 1, Phase 2, Recruiting

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

for
Idiopathic Inflammatory Myopathy, Dermatomyositis,
Location: San Francisco CA, Orange CA, Portland OR,
Sponsor: Cabaletta Bio

Sex: All

Age: 6 - 70+

Code: NCT06154252

Phase 2, Phase 3, Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

for
Lupus Nephritis
Location: San Francisco CA, Loma Linda CA, Aurora CO,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 5 - 17

Code: NCT05039619

Phase 2, Recruiting

A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

for
AADC Deficiency
Location: San Francisco CA, Columbus OH
Sponsor: Krzysztof Bankiewicz

Sex: All

Age: 2+

Code: NCT02852213

Phase 1, Recruiting

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

for
Alpha1-Antitrypsin Deficiency
Location: San Francisco CA, Los Angeles CA, La Jolla CA,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06165341

Phase 3, Recruiting

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

for
Breast Cancer
Location: San Francisco CA, Houston TX, Chicago IL, Nashville TN,
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 18+

Code: NCT03990896

Phase 2, Recruiting